Register Now: Beyond EDC: Designing a Connected Data Strategy for Predictive Clinical Development

Bernd Rosenkranz

Bernd Rosenkranz, FFPM, MD, PhD, is vice president, Clinical Development, Jerini AG, Invalidenstr. 130, D-10115, Berlin, Germany, +49 30 97893 500, fax +49 30 97893 599, email: mbrosenkranz@t-online.de.

Articles by Bernd Rosenkranz

chart1-84711-1408712763756.jpg

Applied Clinical Trials

Both large and small pharmaceutical companies have learned that the value of their development candidates increases once clinical research has demonstrated their proof of concept. Sponsor companies face the challenge of moving new blockbuster drugs to market as rapidly as possible.